Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 2
2006 3
2007 1
2008 2
2009 1
2012 1
2013 1
2014 1
2015 3
2016 1
2017 7
2018 10
2019 4
2020 13
2021 4
2022 3
2023 2
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
A Copeptin-Based Approach in the Diagnosis of Diabetes Insipidus.
Fenske W, Refardt J, Chifu I, Schnyder I, Winzeler B, Drummond J, Ribeiro-Oliveira A Jr, Drescher T, Bilz S, Vogt DR, Malzahn U, Kroiss M, Christ E, Henzen C, Fischli S, Tönjes A, Mueller B, Schopohl J, Flitsch J, Brabant G, Fassnacht M, Christ-Crain M. Fenske W, et al. Among authors: fischli s. N Engl J Med. 2018 Aug 2;379(5):428-439. doi: 10.1056/NEJMoa1803760. N Engl J Med. 2018. PMID: 30067922 Free article.
Diabetes mellitus Typ 1 und Typ 2.
Henzen C, Fischli S. Henzen C, et al. Among authors: fischli s. Ther Umsch. 2020 Sep;77(7):287. doi: 10.1024/0040-5930/a001193. Ther Umsch. 2020. PMID: 32996422 German. No abstract available.
[CME: Adrenal Insufficiency].
Fischli S. Fischli S. Praxis (Bern 1994). 2018 Jun;107(13):717-725. doi: 10.1024/1661-8157/a002982. Praxis (Bern 1994). 2018. PMID: 29921185 Review. German.
Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial.
Pieber TR, Bode B, Mertens A, Cho YM, Christiansen E, Hertz CL, Wallenstein SOR, Buse JB; PIONEER 7 investigators. Pieber TR, et al. Lancet Diabetes Endocrinol. 2019 Jul;7(7):528-539. doi: 10.1016/S2213-8587(19)30194-9. Epub 2019 Jun 9. Lancet Diabetes Endocrinol. 2019. PMID: 31189520 Clinical Trial.
[CME: Primary Hyperparathyroidism].
Egger A, Fischli S. Egger A, et al. Among authors: fischli s. Praxis (Bern 1994). 2018;107(25):1373-1379. doi: 10.1024/1661-8157/a003080. Praxis (Bern 1994). 2018. PMID: 31166875 German.
61 results